Literature DB >> 21617535

Brevundimonas diminuta keratitis.

Rahul T Pandit1.   

Abstract

PURPOSE: To report the first documented case of keratitis secondary to the gram-negative bacillus Brevundimonas diminuta.
METHODS: A 66-year-old woman with an ocular history of bilateral soft contact lens wear presented with a large, 6×9-mm, culture-positive Pseudomonas aeruginosa-induced corneal ulcer. After weeks of therapy, she developed secondary keratitis. Repeat cultures grew a rare, gram-negative bacillus, B. diminuta.
RESULTS: Targeted therapy followed by adjustments based on repeat bacterial cultures with sensitivities resulted in slow resolution of the ulcer. After months of therapy, the cornea recovered leaving only a minimal corneal scar. Visual acuity improved from a low of Hand Motions to a final 20/40.
CONCLUSIONS: This is the first reported case of ocular infection with B. diminuta. This case demonstrates the need to be aware of potential rare secondary infections in corneas compromised by an initial infection and to adjust pharmacotherapy based on sensitivities and clinical signs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21617535     DOI: 10.1097/ICL.0b013e31821c04f7

Source DB:  PubMed          Journal:  Eye Contact Lens        ISSN: 1542-2321            Impact factor:   2.018


  3 in total

1.  First report of an extensively drug-resistant VIM-2 metallo-β-lactamase-producing Brevundimonas diminuta clinical isolate.

Authors:  Marisa N Almuzara; Claudia M Barberis; Carlos H Rodríguez; Angela M R Famiglietti; Maria S Ramirez; Carlos A Vay
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

Review 2.  Besifloxacin: Efficacy and Safety in Treatment and Prevention of Ocular Bacterial Infections.

Authors:  Francis S Mah; Christine M Sanfilippo
Journal:  Ophthalmol Ther       Date:  2016-03-24

Review 3.  Brevundimonas spp: Emerging global opportunistic pathogens.

Authors:  Michael P Ryan; J Tony Pembroke
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.